Molecular Staging and the Selection of Therapy for Non-Small Cell Lung Cancer

被引：2
作者：
D'Amico, Thomas A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Thorac Surg, Durham, NC USA
来源：
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 17卷 / 03期
关键词：
lung cancer; molecular biology; targeted therapy;
D O I：
10.1053/j.semtcvs.2005.06.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The stage-specific selection of therapy is the standard for patients with non-small cell lung cancer. Investigation of the molecular biology of lung cancer has provided pathways and targets that may be used to improve the efficacy of therapy and improve the survival for patients with lung cancer. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：180 / 185
页数：6
相关论文
共 44 条
  • [11] GATZEMEIER U, 2004, P AM SOC CLIN ONCOL
  • [12] Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1
    Giaccone, G
    Herbst, RS
    Manegold, C
    Scagliotti, G
    Rosell, R
    Miller, V
    Natale, RB
    Schiller, JH
    von Pawel, J
    Pluzanska, A
    Gatzemeier, M
    Grous, J
    Ochs, JS
    Averbuch, SD
    Wolf, MK
    Rennie, P
    Fandi, A
    Johnson, DH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 777 - 784
  • [13] An overview of lung cancer genomics and proteomics
    Granville, CA
    Dennis, PA
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 32 (03) : 169 - 176
  • [14] The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers
    Hamada, M
    Fujiwara, T
    Hizuta, A
    Gochi, A
    Naomoto, Y
    Takakura, N
    Takahashi, K
    Roth, JA
    Tanaka, N
    Orita, K
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (06) : 360 - 365
  • [15] HARPOLE DH, 1995, CANCER RES, V55, P51
  • [16] HARPOLE DH, 1995, CANCER-AM CANCER SOC, V76, P787, DOI 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO
  • [17] 2-Q
  • [18] Harpole DH, 1996, ANN THORAC SURG, V61, P1470, DOI 10.1016/0003-4975(96)00104-X
  • [19] Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2
    Herbst, RS
    Giaccone, G
    Schiller, JH
    Natale, RB
    Miller, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 785 - 794
  • [20] HERBST RS, 2004, P AM SOC CLIN ONCOL
12345